Interleukin-21 signaling is important for germinal center B-cell responses, isotype switching and generation of memory B cells. However, a role for IL-21 in antibody-mediated protection against pathogens has not been demonstrated. Here we show that IL-21 is produced by T follicular helper cells and co-expressed with IFN-γ during an erythrocytic-stage malaria infection of Plasmodium chabaudi in mice. Mice deficient either in IL-21 or the IL-21 receptor fail to resolve the chronic phase of P. chabaudi infection and P. yoelii infection resulting in sustained high parasitemias, and are not immune to re-infection. This is associated with abrogated P. chabaudi-specific IgG responses, including memory B cells. Mixed bone marrow chimeric mice, with T cells carrying a targeted disruption of the Il21 gene, or B cells with a targeted disruption of the Il21r gene, demonstrate that IL-21 from T cells signaling through the IL-21 receptor on B cells is necessary to control chronic P. chabaudi infection. Our data uncover a mechanism by which CD4+ T cells and B cells control parasitemia during chronic erythrocytic-stage malaria through a single gene, Il21, and demonstrate the importance of this cytokine in the control of pathogens by humoral immune responses. These data are highly pertinent for designing malaria vaccines requiring long-lasting protective B-cell responses.
Introduction
Malaria is the leading parasitic cause of morbidity and mortality worldwide; about half of the world's population is at risk of infection [1] . There is an urgent need for an effective vaccine able to bring about high levels of protection.
Immunity to the erythrocytic stages of malaria is thought to be primarily dependent on an antibody response. In endemic areas of Plasmodium falciparum transmission, there are associations between Plasmodium-specific antibody responses and protection against infection [2] [3] [4] [5] . Elimination of the erythrocytic-stages of Plasmodium falciparum in infected children can be achieved by passive transfer of immune serum [2, 6] , and studies in experimental models show that B cells and antibodies are important for elimination of chronic infections, and immunity to re-infection [7, 8] . A better understanding of the signals underlying activation of protective, long lasting, B-cell responses would be of great value in malaria vaccine development.
The cytokine IL-21, produced by follicular helper CD4 + T cells (Tfh) and other cells, is important for the generation of B-cell responses in germinal centers (GC), isotype switching, affinity maturation, antibody production, and development of memory B cells (MBC) [9, 10] . However, a requirement of IL-21 for activation and maintenance of Tfh cell is still controversial [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Most of our knowledge about the role of IL-21 in humoral responses has come from studies using immunization with protein antigens, where IL-21 is critical for the development of a T-cell dependent IgG response in GCs [11, 15, 16, 21, 23, 24] . Contrary to its importance in generating B cell responses after immunization, IL-21 seems not to be necessary for all aspects of T-cell-dependent B cell responses in different infection models [14, 19, 20, 22, 25, 26 ]. An investigation into Tfh cell development and the role of IL-21 in malaria has not been carried out, but this would be an excellent infection model in which to determine the importance of IL-21 in protective humoral immunity to a systemic pathogen, and would shed light on the induction, control and impairment of humoral responses in malaria. Here we have used a mouse model of malaria, Plasmodium chabaudi chabaudi AS in C57BL/6 mice, and have shown that IL-21 and Tfh cells are prominently induced and maintained in an erythrocytic-stage infection, suggesting that this crucial element of the humoral response is not impaired. Tfh cells producing IL-21 are multifunctional, with a majority also producing IFN-γ. Importantly, IL-21 produced by CD4 + T cells, acting directly on B cells, is crucial for triggering protective longlasting Plasmodium-specific IgG B cell responses that are required to control and resolve the chronic phase of erythrocytic-stage malaria infection and for immunity to re-infection.
Results

IL-21 signaling is essential to control the chronic phase of blood stage P. chabaudi infection
Injection of 10 5 red blood cells (rbc) infected with P. chabaudi (irbc) into C57BL/6 mice gives rise to an erythrocytic infection, with an early acute parasitemia occurring at day 8 postinfection. Thereafter, the infection is rapidly controlled, reaching very low parasitemia levels by day 20 post-infection. This is followed by a chronic phase of infection, characterized by a prolonged sub-patent parasitemia with small patent recrudescence for up to 60 days before parasite elimination [27] .
To explore a role for IL-21 during erythrocytic-stage P. chabaudi infection, we first determined the pattern of IL-21 mRNA expression in spleens of C57BL/6 mice during a P. chabaudi infection by real-time quantitative RT-PCR. Although IL-21 mRNA was detected over basal naïve levels as early as 2 days post-P. chabaudi infection, there was a striking increase in the spleen by day 7 post-infection, when IL-21 mRNA levels were approximately 130-fold higher than the basal level. IL-21 mRNA decreased thereafter, but remained higher than the basal level for at least 20 days (Fig 1 A) .
We next investigated whether IL-21, or signaling through its receptor, was necessary to control a primary P. chabaudi infection. C57BL/6 mice carrying a targeted deletion of the Il21 gene, or its receptor, Il21r, were infected as described above. They were able to control the acute phase of P. chabaudi infection, despite showing slightly but significantly higher peak parasitemias than infected WT C57BL/6 mice (Fig 1 B) . Similar to WT C57BL/6 mice, both Il21 -/-and Il21r -/-mice had very low parasitemias by 11-14 days post-infection. However, in stark contrast to WT mice, they developed sustained high parasitemias during the chronic phase of infection (e.g., parasitemias of 17% in Il21 -/-and 23% in Il21r -/-mice compared with less than 0.04% in WT C57BL/6 at day 36 post-infection) (Fig 1 B) . These high parasitemias were maintained in both Il21 -/-and Il21r -/-after 120-150 days of infection (44±4% in Il21
-/-and 56±3% in Il21r -/-mice at day 120 post-infection), without mortality. The non-resolving P. chabaudi infection was accompanied by increased anemia in both Il21 -/-and Il21r -/-mice from days 19-22 post-infection onwards (Fig 1 C) . P. yoelii 17X(NL) gives rise to a non-lethal erythrocytic infection in WT C57BL/6 mice that is completely cleared after the acute phase without showing a chronic phase (S1 Fig, A and B) . Similar to the P. chabaudi infection, both Il21 -/-and Il21r -/-mice failed to clear a P. yoelii 17X (NL) erythrocytic infection, and developed sustained high parasitemias (S1 Fig, A and B) . These data show that the requirement for IL-21 signaling is necessary to control infection with different Plasmodium species. P. chabaudi-infected Il21 -/-and Il21r -/-mice showed significantly greater spleen cellularity compared with WT C57BL/6 controls as early as 32 days post-infection, and dramatic splenomegaly at later time points (Fig 1, D 
IL-21 is produced by CD4
+ T cells during P. chabaudi infection, and coexpressed with IFN-γ and IL-10
To identify which cells were responsible for the production of IL-21, intracellular cytokine staining and multiparameter flow cytometry performed on splenic cells from WT C57BL/6 (Fig 1 A) , the percentage and total number of IL-21-producing CD4 + T cells in the spleen increased early after infection, (Fig 2, C and D) .
Both percentages and total numbers decreased thereafter, but remained higher than basal naïve levels at least up to day 32 post-infection. By 120 days post-infection, the frequency and total numbers of IL-21-producing CD4 + T cells in the spleen were comparable to those observed in naïve WT C57BL/6 mice. The majority of IL-21-producing CD4 + T cells in the spleens of WT C57BL/6 mice coexpressed IFN-γ; in particular at the peak of infection, when over 70% of the IL-21-producing CD4 + T cells in the spleen also expressed IFN-γ (Fig 3, A, E and F). The total number of CD4 + T cells co-expressing IL-21 and IFN-γ showed a dramatic increase by day 8 post-infection, remained high at day 15 post-infection, and decreased thereafter (Fig 3 F) . Interestingly, some of the IL-21-producing CD4 + T cells expressing IFN-γ also expressed IL-10 (Fig 3, C-F) . The frequency of these triple producers increased with the progression of the infection until day 32 post-infection, when a maximum of approximately 30% of IL-21-producing CD4 + T cells coexpressed IFN-γ and IL-10 ( Fig 3 D and E) . The highest number of IL-21-producing CD4 + T cells co-expressing IFN-γ and IL-10 was detected at day 15 post-infection (Fig 3 F) . By day 120-140 post-infection, the pattern of cytokines co-expressed with IL-21 resembled that of naïve WT C57BL/6 mice (Fig 3, E wanted to confirm that IL-21 production by T cells was necessary to control P. chabaudi infection. To this end, we generated mixed bone marrow (BM) chimeras in which the deletion of the Il21 gene, or its receptor, was restricted to T cells (Fig 4 A) . Control groups consisted of mixed BM chimeric mice reconstituted with BM obtained from WT C57BL/6 mice, and from Tcra -/- [28] and Ighm [29] mice mixed in an 80:20 ratio. Similar to Il21 -/-and Il21r -/-mice, mixed BM chimeric mice bearing Il21 -/-T cells failed to control the chronic phase of infection and showed increasingly and sustained high parasitemias during this phase of infection (Fig 4 B) . IL-21R signaling on T cells was not required to control P. chabaudi infection, as mixed BM chimeric mice bearing Il21r -/-T cells showed a normal course of P. chabaudi infection when compared with WT C57BL/6 mice or mixed BM chimeric control groups (Fig 4 C) .
Together, these data demonstrate the requirement for IL-21 production by CD4 + T cells to control chronic P. chabaudi infection.
P. chabaudi infection promotes a robust Tfh cell response, even in the absence of IL-21 signaling
Tfh cells collaborate with B cells and are considered to be critical for the development of antigen-specific B cell responses during GC reactions [9, 10] . Tfh cells are a major source of IL-21, and this cytokine has been shown to be important for Tfh cell functionality. Therefore, we assessed the numbers of Tfh cells generated during a P. chabaudi infection, whether these cells were generated, whether they were the source of IL-21, and whether IL-21 was required for their generation and maintenance. . As IL-6 has also been implicated in Tfh differentiation [9] , we determined whether infected Il21 -/-and Il21r -/-mice could produce IL-6, which might explain their ability to generate Tfh cells. In both knockout strains, IL-6 was detected in the plasma at day 6 of infection at levels not significantly different from those of infected WT C57BL/6 controls ( 
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These data show a strong activation of Tfh cell responses during acute P. chabaudi infection, which is not affected by the lack of signaling through the IL-21R. This T cell subset represents an important source of IL-21 at the peak of P. chabaudi infection, and co-expresses IFN-γ.
IL-21 is required to generate P. chabaudi-specific B cell responses, and is necessary for protective immunity against a secondary challenge infection
As IL-21 signaling is required to control the chronic phase of P. chabaudi infection and Tfh cells are an important source of IL-21, we reasoned that the lack of IL-21 signaling would impair the development of protective B cell responses and consequently prevent the resolution of the infection.
Flow cytometric analysis of the different B cell compartments in spleen and BM showed no significant differences in naïve Il21
-/-and Il21r -/-mice compared with those of naïve WT C57BL/6 controls (Fig 6) . (Fig 6, J-L) .
Although there were no differences in the initial numbers of B cells, P. chabaudi-specific IgG antibodies of all isotypes were absent in both Il21 -/-and Il21r -/-mice at all evaluated time points (Fig 7, A and B) . IgM antibodies, on the other hand, were not significantly affected by the lack of IL-21 signaling (Fig 7 C) . In line with the absence of IgG antibodies, there was also a loss of both P. chabaudi-specific IgG antibody-secreting-cells (ASC) in the BM (Fig 7 D) , and of P. chabaudi-specific IgG MBC in the spleen (Fig 7 E) at day 32 post-infection in both Il21
-/-and Il21r -/-mice when compared with WT C57BL/6 controls.
To evaluate whether IL-21 directly signaled B cells to mount an antibody response, and thus to resolve the chronic phase of P. chabaudi infection, we generated mixed BM chimeric mice in which a targeted deletion of the Il21r gene was restricted to B cells (Fig 8 A) . Control groups consisted of mixed BM chimeric mice reconstituted with BM obtained from WT C57BL/6 mice, and from Tcra -/- [28] and Ighm [29] mice mixed in a 20:80 ratio. Similar to the Il21r -/-mice, the mixed BM chimeric mice bearing Il21r -/-B cells eventually developed a nonresolving chronic-stage parasitemia (Fig 8 B) . Furthermore, the mixed BM chimeric mice bearing Il21r -/-B cells, as well as the mixed BM chimeric mice bearing Il21 -/-T cells, but not those bearing Il21r -/-T cells or Il21 -/-B cell, showed a dramatic decrease in the levels of P. chabaudispecific IgG antibodies and in the numbers of P. chabaudi-specific IgG MBC in the spleen (Fig 8, C and D) . C57BL/6 mice develop significant immunity to a second infection with the same strain of P. chabaudi and are able control the challenge infection at very low parasitemias [27] . Because infected Il21
-/-and Il21r -/-mice cannot make P. chabaudi-specific IgG responses, and in particular MBC responses, we reasoned that lack of IL-21 signaling would render these mice unable IL-21-Dependent Control of Malaria P. chabaudi-irbc, treated them with chloroquine 30-45 days post-infection to eliminate the chronic primary infection, and re-challenged them with 10 5 P. chabaudi-irbc of the same strain 3 weeks after drug treatment (Fig 9 A) . In accordance with our previous data, WT C57BL/6 similarly treated with chloroquine during the primary chronic infection were immune to a second challenge with very low parasitemias. In stark contrast, both Il21 -/-and Il21r -/-mice failed to resolve the second infection and showed sustained high parasitemias (Fig 9, B and C 
initial immune control could take place in the absence of an IgG B-cell response (Fig 9, B and  C) . Similarly, Il21r -/-mice also failed to resolve a second infection with P. yoelii 17X(NL), in contrast to WT C57BL/6 controls, which controlled parasitemias at very low levels (S1B Fig) . Similar to Tfh responses during primary infection (Fig 5 A-C and Fig 9 D) , Tfh responses during second P. chabaudi infection (Fig 9 E) and IFN-γ responses of CD4 + T cells during primary and second P. chabaudi infection (Fig 9 F and G) were not altered by the absence of IL-21 signaling. These data show that IL-21 is necessary to activate P. chabaudi-specific IgG B-cell responses, by direct signaling through the IL-21R on B cells, thus resolving the chronic infection. Moreover, IL-21 signaling is required to activate P. chabaudi-specific IgG MBC responses, and to develop immunity to homologous secondary P. chabaudi and P. yoelii 17X(NL) infections.
Discussion
Here we demonstrate, for the first time, a direct requirement of IL-21 signaling on B cells for the elimination of a systemic infection, and its importance in the control of chronic malaria. In the model of P. chabaudi infection in C57BL/6 mice, IL-21 produced by CD4 + T cells, predominantly Tfh cells, during the acute phase of an erythrocytic-stage P. chabaudi infection, is necessary for development of ASC, specific IgG antibodies and MBC, and to bring about the resolution of a chronic P. chabaudi infection. In a similar way, IL-21 signaling was required to control and eliminate a P. yoelii 17X(NL) infection. Our data highlight, for the first time, the importance of IL-21-dependent B-cell responses in the acquisition of immunity to re-infection and suggest that long-lived B-cell responses are required to achieve immunity to malaria reinfection. Both Il21 -/-and Il21r -/-mice failed to produce P. chabaudi-specific IgG antibodies, and did not generate P. chabaudi-specific IgG-producing MBC in the spleen or ASC in the bone Table) . Statistical significance was obtained using the Mann Whitney U test (**, P<0.01). The graph shows the mean ± SEM of the parasitemia at different time points in 7-10 mice per group. (C) MSP1 21 -specific IgG antibodies determined by ELISA 32 days post-infection in different mixed BM chimeric groups (4-5 mice per group, details in S1 Table) . (D) Total number of MSP1 21 -specific IgG MBC in spleens from different mixed BM chimeric groups, determined by ELISPOT on days 120-150 post-infection (4-5 mice per group, details in S1 Table) . Statistical significance was obtained using the Kruskal-Wallis test comparing the data obtained from the group of Rag2 
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marrow showing that IL-21 is required for class switching, and demonstrating that class switching to IgG responses is required for effective control of a P. chabaudi infection. P. chabaudi-specific IgM responses were not altered in the absence of IL-21 signaling. IgM can be produced by short-lived plasmablasts in the spleen, which have not undergone development in GC [32] , perhaps explaining why total plasmablast numbers in the spleen were unaffected by the lack of IL-21 signaling. As we show that IL-21 signaling is required to activate GC B-cell responses upon P. chabaudi infection, we believe that IL-21 signaling is required to activate early stages of T-dependent B-cell responses to the parasites. However, we cannot rule out a direct requirement of IL-21 in the signal pathways leading to class switch recombination and MBC generation. As mixed BM chimeric mice with B cells deficient in IL-21R showed impairment of the humoral response, and did not resolve the chronic phase of P. chabaudi infection, it appears that there is a direct requirement for IL-21 from T cells to signal through the IL-21R on B cells to induce the differentiation of B cells into plasma cells, and thereby for antibody production. Our data is in accordance with those studies showing the critical importance of IL-21 signaling in IgG responses following immunization [11, 15, 23] , but contrasts with studies of other pathogens, where there are variable requirements for IL-21 signaling for B-cell responses. In LCMV-and Influenza-infected mice, the lack of IL-21 signaling results only in slight, or no alterations in induction of B-cell responses, but the IgG antibody response is poorly sustained [19, 22, 25, 26] . Despite decreased levels of IgG1, isotype-switching and GC formation are not altered in Il21r -/-mice infected with H. polygyrus [14] . Primary B-cell responses, but not MBC responses, against live rabies virus-based vaccines, require IL-21 signaling [12] . The reasons for these differential requirements for IL-21 in the different infections/immunizations are not known. It is possible that other signals such as co-stimulation via TLR ligation, cytokines like IL-4, or strength of the BCR signal through extensive BCR cross-linking, could partially compensate for the lack of IL-21 signaling. Intrinsic differences in the antigens and co-stimulations delivered by different infections or immunizations could then differentially engage signals able to compensate different aspects of the B-cell response that would otherwise require signaling through IL-21. In this regard, signaling through TLR7 is known to be able to restore defective B-cell activation in Il21r -/-mice [11] .
The impaired control of parasitemia and loss of the humoral response to P. chabaudi in Il21 -/-and Il21r -/-mice were not due to lack of development of phenotypically-defined Tfh cells. Mice lacking IL-21 or the IL-21R in all cells were able to generate WT levels of Tfh cells; and mice lacking IL-21R only in T cells also had specific B-cell responses similar to those of WT mice. The requirement of IL-21 for the generation or maintenance of Tfh cell responses is controversial. Some studies have shown that IL-21 signaling is required for development, maintenance, or functional competence [15, 16, [19] [20] [21] . However, similar to our studies, others have shown that Tfh cell responses are normal or even elevated in the complete absence of IL-21 signaling [11-14, 17, 18, 22, 23] . Thus, the requirement for IL-21 to activate Tfh responses seems to be highly dependent on the model of immunization or infection studied. In this P. chabaudi infection, direct IL-21 signaling on T cells is not required to activate a functional Tfh program. It is possible that IL-6, which we show here is produced at levels similar to those of infected WT mice, compensates for the lack of IL-21 in the generation of Tfh cells, as has been described [13, 16, 33, 34] . CD8 + T cells have been shown to require IL-21 for protective responses in chronic viral infections in humans and mice [22, 25, 26, [35] [36] [37] , and are known to play some role in controlling erythrocytic-stage Plasmodium infections in mice [38] [39] [40] [41] [42] . Our data rule out a mechanism by which IL-21 acts on or via CD8 + T cells to resolve the chronic P. chabaudi infection, since, in mixed BM chimeric mice in which there is a deficiency of IL-21R only in T cells, there was no exacerbation of the chronic infection.
Despite the failure of Il21 -/-and Il21r -/-mice to resolve their chronic infection, they did not succumb to a fulminating parasitemia within the 100-150 days of the study. One possible factor that may limit the chronic parasitemia is the preference of P. chabaudi for mature rbc [43] . The presence of large numbers of Ter119 + rbc in the spleens of Il21 -/-and Il21r -/-mice indicates increased hematopoiesis in response to anemia, presumably leading to production of many new rbc, which then controls the level of parasitemia. In addition, there are likely to be numerous B-cell-independent innate effector mechanisms activated, which could partially control parasitemia, but unable to completely clear the infection by themselves. Different from infections in Il21 -/-and Il21r -/-mice, mixed BM chimeric mice with B cells deficient in IL-21R did not show a significant difference in relapsing parasitemia compared to WT C57BL/6 mice until days 70-80 post-infection. The higher variability in the parasitemias in these mixed BM chimeric mice compared to Il21r -/-late in infection may reflect B-cell-independent alternate mechanisms, which require IL-21. In general agreement with this idea, IL-21 has been shown to be involved in activation of macrophages and NK cells [44] , both cell types implicated in the control of Plasmodium infection [45] . Previous studies have shown that Th1, Th2 and Th17 CD4 + T cell subsets can also produce IL-21 [9] , and that Tfh cells can express cytokines characteristic of Th1/Th2/Th17 subsets [46] . This suggests either that other subsets of CD4 + T cells can produce IL-21, or that Th1/Th2/ Th17 subsets activated in infections can acquire an additional Tfh phenotype. The generation of different CD4 + T cell subsets during infections is a very dynamic process, and activated CD4 + T cells, including Tfh cells, show substantial plasticity with overlapping phenotypes [47] .
In the case of P. chabaudi infection, IL-21 production by CD4 + T cells was strongly linked to that of IFN-γ, the hallmark cytokine of Th1 CD4 + T cells, reflecting the strong bias to a Th1 response during acute P. chabaudi infection. We found no IL-4/IL-21 double-producing cells, and there is little induction of IL-17 in the spleens of P. chabaudi-infected mice [48] . Later in the course of P. chabaudi infection (13-15 days), we observed the appearance of splenic CD4 + T cells co-expressing IL-21, IFN-γ and IL-10. IL-10 may have been induced in these cells in order to regulate the inflammatory response and thus immune-mediated pathology, as we have shown previously [49, 50] . IL-21-producing CD4 + T cells are present in peripheral blood mononuclear cells from malaria-exposed immune adults [51, 52] and correlate with P. falciparum-specific IgG antibodies in children with acute falciparum malaria [53] . These observations encourage us to believe that use of the mouse model of P. chabaudi is a valid approach to dissect the regulation and role of IL-21, Tfh and B-cell responses, which is also relevant to other infections dependent on humoral immunity for their elimination. In summary, we show that the absence of IL-21 signaling on B cells results in a loss of capacity to activate Plasmodium-specific IgG antibodies and memory B cells, resulting in a failure to resolve a chronic erythrocytic-stage infection with P. chabaudi and an inability to control a secondary challenge infection. This important immune mechanism should receive particular attention when exploring novel vaccine strategies.
Materials and Methods
Ethics statement
All animal experiments were approved by the MRC NIMR institutional Ethical Review Panel and carried out according to UK National guidelines (Scientific Procedures) Act 1986 under license PPL80/2385 approved by the British Home Office.
Mice
C57BL/6, Ighm [29] , Tcra -/- [28] and Rag2 -/- [54] mouse strains were bred in the specific pathogen-free facilities of the MRC NIMR and were backcrossed for at least 10 generations onto NIMR C57BL/6 mice. Mice with a targeted deletion of the Il21 gene, originally from NIH MMRRC (F2 129/ SvEvBrd x C57BL6/J), were obtained from Manfred Kopf, Institute for Molecular Health Sciences, Zürich, Switzerland. They were backcrossed 3 generations to C57BL/6J at the Garvan Institute, Sydney, and then backcrossed for 5 generations by Manfred Kopf and a further 3 generations onto NIMR C57BL/6 mice. Il21r -/-mice backcrossed to C57BL/6 (N7)
were a kind gift from Manfred Kopf [55] , and were further backcrossed 3 times onto NIMR C57BL/6. In all experiments, NIMR C57BL/6 bred in the same animal house were used as controls. From a panel of 768 SNPs, NIMR C57BL/6 and C57BL/6/J mice differ only by 2 SNPs; one each on chromosomes 2 and 12.
Mixed BM chimeras
The Il21 -/-and Il21r -/-mice were crossed with Ighm and Tcra -/-to obtain double knockout
-/-, and Tcra -/-Il21r -/-. To generate mixed BM chimeric mice in which either B or T cells were deficient in the expression of IL-21 or IL-21R, femurs and tibias from donor mice were excised and cleaned of flesh using forceps and scalpel, and BM was obtained by flushing out with IMDM supplemented with 2 mM L-glutamine, 0.5 mM sodium pyruvate, 100 U penicillin, 100 mg streptomycin, 6 mM Hepes buffer, and 50 mM 2-ME (all from Gibco, Invitrogen), using a syringe with a needle. Thereafter, single BM cell sus Infection of mice with P. chabaudi and P. yoelii Mice were infected with 10 5 P. chabaudi chabaudi AS-infected or 10 3 P. yoelii 17X(NL)-infected rbc by i.p. injections, and parasitemias monitored by Giemsa-stained blood films, as previously described [56] . The total number of rbc and hemoglobin concentrations were determined using a Vetscan (Abaxis), and body ventral temperature was measured using a MiniTemp MT6 infrared thermometer (Raytek).
Drug treatment
Drug-mediated elimination of P. chabaudi infection in Il21 -/-, Il21r -/-and WT C57BL/6 mice was accomplished with 10 i.p. injections of 40 mg chloroquine (Sigma)/kg body weight in 0.9% sodium chloride solution given in 10 consecutive days, starting on day 30-45 post-primary infection. Drug-mediated elimination of P. yoelii in Il21r -/-and WT C57BL/6 was accomplished with chloroquine given in drinking water (600mg/L) during 6 consecutive days, followed by 3 i.p. injections of 0.25 mg pyrimethamine (Sigma) given in 3 consecutive days, followed by 3 i.p. injections of 1.25 mg of artesunat (Pharbaco) given in 3 consecutive days. Elimination of parasitemia was monitored by Giemsa-stained blood films and, in the case of P. chabaudi infection, to verify complete elimination of parasitemia after chloroquine treatment, 50 μl of blood were obtained from each mouse, diluted in 350 μl Kreb's saline containing glucose (11 mM) and heparin (50 mU) and subinoculated into Rag2 -/-mice. Giemsastained thin blood films from the recipient Rag2 -/-mice were monitored for 3 weeks [27] . A second infection of 10 5 P. yoelii-infected rbc was given to Il21r -/-and WT C57BL/6 control mice 3 days after the last artesunat injection.
Quantitative real-time PCR
Expression of IL-21 mRNA was measured as previously described [48] . Briefly, total RNA was extracted from splenocytes from uninfected and P. chabaudi-infected C57BL/6 mice with TRIzol reagent (Life Technologies), reverse transcribed, and IL-21 mRNA was measured using real-time quantitative PCR with the primers, forward TCATCATTGACCTCGTGGCCC and reverse ATCGTACTTCTCCACTTGCAATCCC.
Flow cytometry
Spleens were dissected and single cell suspension was obtained by mashing the organs through a 70 μm filter mesh in HBSS (Gibco, Invitrogen). After removal of rbc by treatment with lysing buffer (Sigma), the remaining cells were resuspended in complete IMDM [IMDM supplemented with 10% FBS Serum Gold (PAA Laboratories, GE Healthcare), 2 mM L-glutamine, 0.5 mM sodium pyruvate, 100 U penicillin, 100 mg streptomycin, 6 mM Hepes buffer, and 50 mM 2-ME (all from Gibco, Invitrogen)] and viable cells were counted using trypan blue exclusion (Sigma) and a hemocytometer. Cells were then resuspended in PBS containing 2% FBS, 0.1% N a N 3 (staining buffer), with the monoclonal anti-mouse CD16/32 [24G2, [57] ] to block Fc-mediated binding of antibodies. To identify Tfh cells, 2x10 6 cells were first incubated with biotin anti-CXCR5 in complete IMDM (BD Pharmingen), washed twice with staining buffer, resuspended in PBS and incubated with appropriate dilutions of PE or APC streptavidin, PE/ Cy7 anti-PD-1, APC/Cy7 anti-CD4, FITC or PerCP/Cy5.5 anti-CD44 and APC or Pacific Blue anti-CD3e (Biolegend). Cells were fixed with 2% paraformaldehyde and stored in staining buffer at 4°C until acquisition. For B cell analysis, spleens and BM (1 femur plus 1 tibia) were prepared as described above, and 2x10 6 cells were first incubated with anti-mouse CD16/32, followed by surface staining with different combinations of BV605 or BV785 anti-CD19, APC or PE/Cy7 anti-B220, BV421 anti-IgD, PerCP/Cy5.5 anti-IgM (all from Biolegend), FITC anti-GL-7, PE anti-CD138 (BD Pharmingen) and APC anti-CD38 (eBioscience), and acquired after two washes with PBS. To identify the different cell populations in the spleen, 2x10 6 cells were first incubated with anti-mouse CD16/32, followed by surface staining with different combinations of BV785 anti-CD19, BV711 anti-NK1.1, BV650 anti-CD8, BV605 anti-CD4, BV421 anti-γδTCR, PerCP/Cy5.5 anti-Ly6G, FITC anti-MHCII, PE anti-Ly6C, APC/Cy7 anti-Ter119, alexa fluor 700 anti-CD3 and alexa fluor 647 anti-CD11c (all from Biolegend), and acquired after two washes with PBS. For intracellular cytokine staining, cells were stimulated for 5h in complete IMDM with PMA (50 ng/mL; Sigma), Ionomycin (500 ng/mL; Sigma), and Brefeldin A (10 mg/mL; Sigma), and surface stained as described above. Intracellular staining for IL-21-producing Tfh cells was performed as described [58] [59] [60] . Briefly, cells were fixed in 2% paraformaldehyde and stored in staining buffer overnight at 4°C, permeabilized in Perm/Wash buffer (BD Pharmingen), and incubated in Perm/Wash with recombinant mouse IL-21 receptor/ human Fc chimera (5mg/ mL; R&D Systems). Cells were then stained with R-Phycoerythrin-conjugated AffiniPure F (ab') 2 Fragment Goat Anti-Human IgG (Jackson ImmunoResearch). For the study of cytokines co-expressed with IL-21, cells were further stained with PE/Cy7 anti-IFN-γ, FITC anti-IL-10, alexa fluor 647 anti-IL-4 (all from Biolegend) or FITC anti-IFN-γ (eBioscience). Intranuclear staining of Bcl-6 was performed using PE anti-Bcl-6 (eBioscience) and the Foxp3/Transcription Factor Staining Buffer Set (eBioscience), following manufacturer's manual. Cells were acquired on CyAn ADP (Beckman Coulter), BD FACSVerse, BD LSRII or BD LSRFortessa X-20 (BD Biosciences) flow cytometers. Dead cells were excluded by staining with LIVE/DEAD Fixable Aqua or Blue stain (Invitrogen). Singlets were selected based on FCS-A vs FCS-W and further based on SSC-A vs SSC-W. "Fluorescence minus one" (FMO) controls, in combination with isotype controls, were used to set the thresholds for positive/negative events. Analysis was performed with FlowJo software version 9.6 or higher (Tree Star).
ELISPOT assays
ELISPOTs to measure ex-vivo frequencies of P. chabaudi-specific ASC in BM and MBC in spleen were performed as previously described [61] . Cells were incubated for 5h on 96-wells Multiscreen-HA filter plates (Millipore) coated with the C-terminal 21kDa part of P. chabaudi merozoite surface protein 1 (MSP1 21 ) , prepared as described [62] , to measure the frequency of MSP1 21 -specific ASC, or coated with affinity-purified goat anti-mouse IgG (Sigma), to measure the frequency of total IgG ASC. Spots were enumerated with an Immunospot analyzer (CTL, Germany).
For MBC ELISPOTs, spleen cells were obtained by mashing the spleens through a 70 μm filter strainer, and rbc were eliminated by treatment with lysing buffer (Sigma). Cells were polyclonally activated by incubation for 6 days in flat-bottomed 96-well plates in the presence of irradiated feeder splenocytes, LPS, and supernatant from concanavalin A-stimulated C57BL/6 spleen cells. Four-fold dilutions of splenocytes were tested in replicates of 22 wells each. Cells were then transferred to antigen-coated 96-well Multiscreen-HA filter plates (Millipore) for ASC ELISPOT performed as described above. Precursor frequencies were calculated with ELDA software [63] .
ELISA
Serum samples were obtained periodically after P. chabaudi infection by bleeding the mice from the tail vein. MSP1 21 and whole parasite lysate were generated and used in ELISAs to measure specific IgM, IgG and IgG subclasses, as previously described [64] .
Statistical analysis
Statistical analysis was performed using Mann Whitney U test or Kruskal-Wallis test on Prism software version 6 (GraphPad). P<0.05 was accepted as a statistically significant difference.
Accession numbers
• Ighm Ig mu chain C region [Mus musculus]; Gene ID: 102641210; Uniprot ID: P01872
• Tcra T-cell receptor alpha chain C region [Mus musculus]; Gene ID: 21473; Uniprot ID: P01849 Supporting Information 
